Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRA-216 in COPD With Type 2 Inflammation
NCT07730281Phase 2Recruiting
- Sponsor
- Prana Therapies
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of PRA-216 in chronic obstructive pulmonary disease (COPD), sponsored by Prana Therapies. Started Aug 2026; status: recruiting.
02
Drugs
PRA-216
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07730281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730281.